Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Nutex Health, Inc. (IGMB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/05/2023 4 Hosseinion Warren (President) has filed a Form 4 on Nutex Health, Inc.
Txns: Gifted 141,000 shares @ $0
Gifted 50,000 options to buy @ $1.5, valued at $75k
Gifted 10,795 warrants @ $6.67, valued at $72k
09/26/2023 SC 13G/A Premier Macy Management Holdings, LLC reports a 5% stake in NUTEX HEALTH INC.
08/23/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ACQUISITION EXPANDS COMPANY’S PRESENCE IN FLORIDA AND ADDS APPROXIMATELY 112 PRIMARY CARE PHYSICIANS AND 4400 MANAGED CARE PATIENTS TO THE NUTEX PLATFORM"
08/09/2023 8-K Quarterly results
Docs: "NET revenue of $58.9 million"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/07/2023 SC 13G Premier Macy Management Holdings, LLC reports a 6.3% stake in NUTEX HEALTH INC.
07/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Second Amended and Restated Certificate of Incorporation",
"Nutex Health Inc. 2023 Employee Stock Purchase Plan"
06/16/2023 4 Grenas Cheryl Yvonne (Director) has filed a Form 4 on Nutex Health, Inc.
Txns: Bought 10,000 shares @ $0.43, valued at $4.3k
05/26/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
05/19/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/18/2023 4 Waters John J (Director) has filed a Form 4 on Nutex Health, Inc.
Txns: Bought 50,000 shares @ $0.469, valued at $23.5k
05/15/2023 8-K Quarterly results
Docs: "NET revenue of $56.3 million"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 3 Stites Danniel (Director) has filed a Form 3 on Nutex Health, Inc.
05/11/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/09/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/06/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NUTEX HEALTH announces change to its board of directors"
03/27/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
03/10/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/02/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Total revenue of $219.3 million for the year ended 2022",
"Supplemental Financial Disclosures"
03/02/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
01/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Cancellation Agreement"
12/30/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/30/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/30/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/30/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/21/2022 8-K Quarterly results
12/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 8-K Quarterly results
Docs: "NUTEX HEALTH reports THIRD quarter 2022 financial results and announces Common stock purchase agreement for a commitment to purchase up to $100 million worth of shares of its common stock with lincoln park capital"
11/21/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/18/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "THE COMPANY:",
"REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT , dated as of November 14, 2022, is made by and between NUTEX HEALTH INC., a Delaware corporation , and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company . Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof . WHEREAS: The Company has the right, upon the terms and subject to the conditions of the Purchase Agreement, to sell and issue to the Buyer up to One Hundred Million Dollars of Purchase Shares and to induce the Buyer to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities Act of 1933, as amended..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy